Jamie E Chaft, MD is an Associate Attending Physician at Mememorial Sloan Kettering Cancer Center where she serves as the Director of Early Stage Lung Cancer Research. She designs and leads clinical trials striving to improve the cure rates in early stage lung cancers. In such a capacity, she serves as Study Chair for the NCTN trial of adjuvant nivolumab within the ALCHEMIST program and co-lead of the LCRF LEADER study bringing personalized neoadjuvant therapies to patients with resectable lung cancer. Dr. Chaft's career is committeed to moving drugs shown to have promise in more advanced lung cancers into the early stage setting.